- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: March 2016
- Public Summary Document (PSD) March 2016 PBAC Meeting - PDF
- Public Summary Document (PSD) March 2016 PBAC Meeting - Word
Ocriplasmin – March 2016
Ocriplasmin: 0.5 mg/0.2 mL injection, 1 x 0.2 mL vial, Jetrea®
Last updated
1 July 2016